Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial
2024 · The Journal of Headache and Pain · 26 citations
https://doi.org/10.1186/s10194-024-01731-4